4HG0 Stock Overview
A med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Qlife Holding AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.25 |
| 52 Week High | SEK 40.00 |
| 52 Week Low | SEK 0.098 |
| Beta | 0.73 |
| 11 Month Change | 23.00% |
| 3 Month Change | 23.00% |
| 1 Year Change | -95.27% |
| 33 Year Change | -100.00% |
| 5 Year Change | n/a |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4HG0 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 9.8% | 1.3% | 2.6% |
| 1Y | -95.3% | 5.6% | 3.8% |
Return vs Industry: 4HG0 underperformed the German Medical Equipment industry which returned 5.6% over the past year.
Return vs Market: 4HG0 underperformed the German Market which returned 3.8% over the past year.
Price Volatility
| 4HG0 volatility | |
|---|---|
| 4HG0 Average Weekly Movement | 38.2% |
| Medical Equipment Industry Average Movement | 5.1% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.1% |
| 10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: 4HG0's share price has been volatile over the past 3 months.
Volatility Over Time: 4HG0's weekly volatility has decreased from 889% to 38% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 11 | Thomas Warthoe | www.qlifeholding.com |
Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents. The company offers Egoo Health Platform, an integrated platform with a measuring instrument with disposable capsules and software, where each capsule contains a test for a specific biomarker or virus.
Qlife Holding AB (publ) Fundamentals Summary
| 4HG0 fundamental statistics | |
|---|---|
| Market cap | €498.44k |
| Earnings (TTM) | -€13.31m |
| Revenue (TTM) | €10.63k |
46.9x
P/S Ratio0.0x
P/E RatioIs 4HG0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4HG0 income statement (TTM) | |
|---|---|
| Revenue | SEK 121.00k |
| Cost of Revenue | SEK 5.17m |
| Gross Profit | -SEK 5.05m |
| Other Expenses | SEK 146.48m |
| Earnings | -SEK 151.53m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Nov 07, 2024
| Earnings per share (EPS) | -82.79 |
| Gross Margin | -4,170.25% |
| Net Profit Margin | -125,228.93% |
| Debt/Equity Ratio | -27.2% |
How did 4HG0 perform over the long term?
See historical performance and comparison